Comparison of two methods of estimation of low density lipoprotein cholesterol, the direct versus Friedewald estimation

Indian Journal of Clinical Biochemistry

Volumn 20, Issue 2, 2005, Pages 54-61

  Sahu, Suchanda ^a   Chawla, Rajinder ^a   Uppal, Bharti ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Direct assay; Friedewald's method; High density lipoprotein cholesterol (HDL C); Low density lipoprotein cholesterol (LDL C); Total cholesterol (TC); Triglyceride (TG)

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SURFACTANT; TRIACYLGLYCEROL;

ARTICLE; ASSAY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION COEFFICIENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC KIT; DIET RESTRICTION; DISEASE CLASSIFICATION; FRIEDEWALD METHOD; HUMAN; HYPERCHOLESTEROLEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; SOLUBILITY; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 24044446146     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02867401     Document Type: Article

References (38)

1. Rifai, N. (1986) Lipoproteins and Apolipoproteins. Composition, metabolism and association with coronary heart disease. Arch. Pathol. Lab. Med. 110, 694-701.
2. Rifai, N., Warnick, G.R., McNamara, J.R., Belcher, J.D. et al. (1992) Measurement of Low Density Lipoprotein Cholesterol in serum: A Status Report. Clin. Chem. 38(1), 150-160.
3. Grouse, J.R., Parks, J.S., Schey, H.M. and Kahl, F.R. (1985) Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J. Lipid Res. 26, 566-574.
4. Anderson, K.M., Castelli, W.P. and Levy, D. (1987) Cholesterol and Mortality: 30 years of follow-up from the Framingham Study. JAMA 257, 2176-2180.
5. Gordon, T., Kennel, W.D., Castelli, W.P. and Dauber, T.R. (1981) Lipoproteins, Cardiovascular Disease and Death: The Framingham Study. Arch. Intern. Med. 141, 1128-1131.
6. Newman, W.P., Freedman, D.S., Voors, A.W. et al. (1986) Relation of serum lipoprotein levels and systolic blood pressure to early arterioscleroses: The Bogalusa Heart Study. N Engl. J. Med. 314, 138-144.
7. Scandinavian Simvastin Survival Study Group. (1994) Randomized trial of Cholesterol lowering in 44,444 patients with Coronary Heart Disease: The Scandinavian Simvastin Survival Study (4S). Lancet 344, 1383-1389.
8. Brown, B.J., Albers, J.J., Fisher, L.D. et al. (1990) Regression of Coronary Artery Disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med. 323, 1289-1298.
9. Nauck, M. and Rifai, N. (2000) Analytical Performance and Clinical efficacy of three routine procedures for LDL Cholesterol measurement compared with the ultracentrifugation-dextransulfate- Mg (2+) method. Clin. Chim. Acta. 294 (1-2), 77-92.
10. Third Report of The National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2001). Executive summary. JAMA 285, 2486-2497.
11. Fei, H., Maeda, S., Kirii, H., Fujigaki, S. et al. (2000) Evaluation of Two Different Homogenous Assays for LDL-Cholesterol in Lipoprotein-X-Positive Serum. Clin. Chem. 46, 1351-1356.
12. Marniemi, J., Maki, J., Maatela, J., Jarvisalo, J. and Impivaara, O. (1995) Poor applicability of Friedewald formula in the assessment of serum LDL- Cholesterol for Clinical purposes. Clin. Biochem. 28, 285-289.
13. Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative centrifuge. Clin. Chem. 18, 499-502.
14. Bachorick, P.S. and Ross, J.W. (1995). For The National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: Executive Summary. Clin. Chem. 41, 1414-1420.
15. McNamara, J.R., Cohn, J.S., Wilson, P.W. and Schaefer, E.J. (1990) Calculated values for low-density lipoprotein cholesterol in the measurement of lipid abnormalities and coronary disease risk. Clin. Chem. 36, 36-42.
16. Sugiuchi, H., Irie, T., Uji, Y., Ueno, T., Chaen, T., Uekama, K. and Okabe, H. (1998) Homogenous assay for measuring low density lipoprotein cholesterol in serum with triblock copolymer and Mg (2+) cyclodextrin sulphate. Clin. Chem. 44, 522-531.
17. Rifai, N., Iannotti, E., DeAngelis, K. and Law, T. (1998) Analytical and Clinical performance of homogenous enzymatic LDL Cholesterol assay compared with ultracentrifugation dextran sulphate Mg 2+ method. Clin. Chem. 44, 1242-1250.
18. Meiattini, F., Prencipe, L., Bardelli, F., Giannini, G. and Tarli, P. (1978) The 4-hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymatic determination of serum cholesterol. Clin. Chem. 24, 2161-2165.
19. Bucolo, G. and David, H. (1973) Quantitative determination of serum triglycerides by use of enzymes. Clin. Chem. 19, 476-482.
20. Fossati, P. and Prencipe, L. (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 28, 2077-2080.
21. Isezaki, M., Shirahata, K., Seto, H. et al. (1996) J. Clin. Lab. Inst. Reag. 19, 349-353 (in Japanese).
22. Nakamura, M., Taniguti, Y., Yamamoto, M., Hino, K. and Manabe, M. (1997) Homogenous assay of serum LDL Cholesterol on an auto analyzer. Clin. Chem. 43 (6), S260-S261.
23. Allain, C.C., Poon, L.S., Clen, C.S.G., Richmond, W. and Fu, P.C. (1974) Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470-475.
24. Lippi, U., Graziani, M.S., Manzato, F. and Michella, Schinella. (1986) Response to letter to editor. Clin. Chem. 32 (5), 910-911.
25. Wilson, P.W., Abbott, R.D., Garrison, R.J. et al. (1981) Estimation of very low-density lipoprotein cholesterol from data on triglyceride concentration in plasma. Clin. Chem. 27, 2008-2010.
26. Sakaue, T., Hirano, T., Yoshino, G., Sakai, K., Takeuchi, H. and Adachi, M. (2000) Reactions of direct LDL cholesterol assays with pure LDL fraction and LDL: Comparison of three Homogenous methods. Clin. Chim. Acta. 295 (1-2), 97-106.
27. Yu, H.H., Markowitz, R., De Ferranti, S.D., Neufeld, E.J., Farrow, G., Bernstein, H.H. and Rifai, N. (2000) Direct measurement of LDL cholesterol in children: Performances of two surfactant- based methods in general pediatric population. Clin. Biochem. 33 (2), 89-95.
28. Harris, N., Neufeld, E.J., Neuberger, J.W. et al. (1996) Analytical performance and Clinical utility of a direct LDL- Cholesterol assay in a hyperlipidemic pediatric population. Clin. Chem. 42, 1182-1188.
29. Bethesda, M.D., Nauck, et al. (1995) National Cholesterol Education Program. Recommendations on Lipoprotein measurement. Working Group on Lipoprotein measurement. NIH Publication No.95-3C44. Methods for LDL-C with emphasis on Homogenous Assays.
30. Castelli, W.P., Garrison, R.J., Wilson, P.W., Abbott, R.D., Kalousdian, S., Kammel, W.B. (1986) Incidence of Coronary Heart Disease and Lipoprotein levels: The Framingham Study. JAMA 256, 2835-2838.
31. Randomized Trials of Cholesterol lowering in 4444 patients with Coronary Heart Disease: The Scandinavian Simvastin Survival Study (4S). Lancet 344, 1383-1389.
32. Warnick, G.R., Knopp, R.H., Fitzpatrick, V. and Branson, I. (1990) Estimating low density lipoprotein cholesterol by Friedewald equation is adequate for classifying patients on the basis of nationally recommended cut points. Clin. Chem. 36, 15-19.
33. Nauck, M., Wanick, G.R. and Rifai, N. (2002) Methods of Measurement of LDL- Cholesterol: A Critical Assessment of Direct Measurement by Homogenous Assays versus Calculation. Clin. Chem. 48 (2), 236-254.
34. Miller, W.G., Waymack, P.P., Anderson, F.P., Ethridge, S.F. and Jayne, E.G. (2002) Performance of four homogenous Direct Methods for LDL- Cholesterol. Clin. Chem. 48 (3), 489-498.
35. Hsia, S.H. (2003) Editorial: Non- HDL Cholesterol: Into the Spotlight. Diabetes Care. Alexandria, 26 (1), 240-242.
36. Whiting, M.J., Shepard, M.D.S. and Talus, G.A. (1997) Measurement of plasma LDL- Cholesterol in patients with diabetes. Diabetes Care 20, 12-14.
37. Lu, W., Resnick, H.E., Jablonski, K.A., Jones, K.L., Jain, A.K., Howard, W.J., Robbins, D.C. and Howard, B.V. (2003) Non- HDL Cholesterol as a predictor of Cardiovascular Disease in Type 2 Diabetes: the Strong Heart Study. Diabetes Care 26, 16-23.
38. Yu, H.H., Ginsburg, G.S., Harris, N. and Rifai, N. (1997) Evaluation and clinical application of direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am. J. Cardiol. 80, 1295-1299.